MX2019006941A - Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. - Google Patents

Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.

Info

Publication number
MX2019006941A
MX2019006941A MX2019006941A MX2019006941A MX2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A
Authority
MX
Mexico
Prior art keywords
alleviating
preventing
carbamate compound
tremor syndrome
tremors
Prior art date
Application number
MX2019006941A
Other languages
English (en)
Inventor
Ju Yi Han
Uk Yoo Jin
Sung Lee Hye
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of MX2019006941A publication Critical patent/MX2019006941A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona a un uso de una composición farmacéutica que incluye un compuesto de carbamato de la fórmula química 1 y se administra para prevenir, aliviar o tratar temblores o el síndrome de temblor.
MX2019006941A 2016-12-14 2017-12-14 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. MX2019006941A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160170225 2016-12-14
PCT/KR2017/014743 WO2018111009A1 (ko) 2016-12-14 2017-12-14 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
MX2019006941A true MX2019006941A (es) 2019-09-06

Family

ID=62558966

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006941A MX2019006941A (es) 2016-12-14 2017-12-14 Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.

Country Status (13)

Country Link
US (1) US11033531B2 (es)
EP (1) EP3556364A4 (es)
JP (1) JP7086076B2 (es)
KR (1) KR102635941B1 (es)
CN (1) CN110267657B (es)
AU (1) AU2017374459B2 (es)
BR (1) BR112019012000A2 (es)
CA (1) CA3046300A1 (es)
CL (1) CL2019001623A1 (es)
IL (1) IL267191B2 (es)
MX (1) MX2019006941A (es)
WO (1) WO2018111009A1 (es)
ZA (1) ZA201903749B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3711760B1 (en) * 2017-11-14 2024-02-14 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
CN113015524A (zh) * 2018-09-21 2021-06-22 爱思开生物制药株式会社 氨基甲酸酯化合物和包含其的制剂在预防、缓解或治疗急性应激障碍或创伤后应激障碍中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291454T3 (es) * 2001-02-27 2008-03-01 Ortho-Mcneil Pharmaceutical, Inc. Utilizacion de carbamatos para prevenir o tratar trastornos del movimiento.
EP1732564A1 (en) * 2004-03-29 2006-12-20 Merck & Co., Inc. Biaryl substituted pyrazinones as sodium channel blockers
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
KR101145395B1 (ko) * 2007-03-05 2012-07-10 인두스 바이오텍 프라이빗 리미티드 트리고넬린 및 4-하이드록시이소류신을 포함하는 약제학적 조성물 및 그 제조방법
RU2508290C2 (ru) 2009-06-22 2014-02-27 ЭсКей БАЙОФАРМАСЬЮТИКАЛЗ КО., ЛТД. Способ получения (r)-1-арил-2-тетразолилэтилового эфира карбаминовой кислоты
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CN105228604A (zh) 2013-03-12 2016-01-06 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Also Published As

Publication number Publication date
JP2020502137A (ja) 2020-01-23
EP3556364A1 (en) 2019-10-23
CL2019001623A1 (es) 2019-08-23
RU2019121914A (ru) 2021-01-15
ZA201903749B (en) 2022-01-26
IL267191A (es) 2019-07-31
IL267191B1 (en) 2023-01-01
CN110267657B (zh) 2022-12-13
US11033531B2 (en) 2021-06-15
AU2017374459B2 (en) 2023-04-27
IL267191B2 (en) 2023-05-01
KR102635941B1 (ko) 2024-02-13
WO2018111009A1 (ko) 2018-06-21
CN110267657A (zh) 2019-09-20
KR20190087573A (ko) 2019-07-24
US20190336481A1 (en) 2019-11-07
BR112019012000A2 (pt) 2019-10-29
CA3046300A1 (en) 2018-06-21
AU2017374459A1 (en) 2019-07-04
EP3556364A4 (en) 2020-06-17
RU2019121914A3 (es) 2021-04-21
JP7086076B2 (ja) 2022-06-17

Similar Documents

Publication Publication Date Title
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
MX2022012313A (es) Oxisteroles y metodos de uso de los mismos.
WO2017204445A3 (ko) Alk 단백질의 분해를 유도하는 약학적 조성물 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
NZ729005A (en) Aminopyrimidinyl compounds as jak inhibitors
PH12017500416A1 (en) Compounds and compositions as raf kinase inhibitors
PH12019501690A1 (en) Pyrimidine compound and pharmaceutical use thereof
MY196186A (en) Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor
MX2018005041A (es) Compuestos para tratar la esclerosis lateral amiotrofica.
PH12019500196A1 (en) Compounds and compositions and uses thereof
NZ730250A (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
MX2017008083A (es) Compuestos 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2h-pirrol-5-amina inhibidores de beta-secretasa.
MX2018014080A (es) Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.
MX2019006863A (es) Inhibidores de heparanasa y uso de los mismos.
MX2022006229A (es) Composiciones y metodos para el tratamiento de resistencia a la insulina.
PH12019500198A1 (en) Compounds and compositions and uses thereof
SG10201907291QA (en) Monomethylfumarate prodrug compositions
PH12020550252A1 (en) Novel phenylpyridine derivative and pharmaceutical composition comprising the same
MX2019006940A (es) Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar.
MX2019006941A (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
MX2017013281A (es) Metodos para tratar transtornos del almacenamiento lisosomal.
MX2018014081A (es) Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal.
MX2018003565A (es) Derivados de 2,3,4,5-tetrahidropiridin-6-amina.
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
MX2016008968A (es) Compuestos organicos.